Crystalline glucosamine sulfate in the treatment of osteoarthritis: evidence of long-term cardiovascular safety from clinical trials.
CONCLUSIONS: Long-term use of CGS did not affect blood pressure, lipids, or glucose in patients with osteoarthritis. These findings further support the cardiovascular safety of CGS.
PMID: 22216067 [PubMed]
Source: Open Rheumatology Journal - Category: Rheumatology Tags: Open Rheumatol J Source Type: research
More News: Cardiology | Cardiovascular | Cholesterol | Clinical Trials | Glucosamine | Heart | Hypertension | Osteoarthritis | Rheumatology | Study